BeiGene Long Term Debt vs Short Term Investments Analysis

BGNE Stock  USD 190.51  4.05  2.08%   
BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene Long Term Debt and its Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

Long Term Debt vs Short Term Investments

Long Term Debt vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene Long Term Debt account and Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between BeiGene's Long Term Debt and Short Term Investments is 0.51. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's Long Term Debt and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of BeiGene are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Long Term Debt i.e., BeiGene's Long Term Debt and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.51
Relationship DirectionPositive 
Relationship StrengthWeak

Long Term Debt

Long-term debt is a debt that BeiGene has held for over one year. Long-term debt appears on BeiGene balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on BeiGene balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Short Term Investments

Short Term Investments is an item under the current assets section of BeiGene balance sheet. It contains any investments BeiGene undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that BeiGene can easily liquidate in the marketplace.
Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 17.4 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.84.
 2021 2022 2023 2024 (projected)
Interest Expense15.8M52.5M37.4M39.2M
Depreciation And Amortization46.5M66.3M87.7M92.1M

BeiGene fundamental ratios Correlations

0.860.880.851.00.950.940.710.68-0.92-0.820.810.920.77-0.180.650.770.990.870.90.650.940.960.90.920.71
0.860.980.960.830.860.950.960.41-0.89-0.990.980.940.96-0.190.320.730.80.960.890.320.840.880.990.970.96
0.880.980.990.860.920.980.950.43-0.91-0.970.930.950.97-0.050.450.680.840.940.870.370.80.860.990.990.94
0.850.960.990.830.910.970.950.38-0.88-0.950.920.920.980.050.420.650.80.930.840.360.750.810.970.980.94
1.00.830.860.830.950.930.680.7-0.92-0.790.780.910.74-0.190.680.760.990.850.880.680.940.950.890.90.68
0.950.860.920.910.950.960.750.64-0.87-0.820.810.890.810.010.630.680.950.870.840.690.860.850.90.940.73
0.940.950.980.970.930.960.880.52-0.94-0.930.910.960.92-0.060.550.730.920.950.880.50.860.90.980.990.87
0.710.960.950.950.680.750.880.2-0.8-0.970.940.860.99-0.040.190.620.630.910.790.10.650.740.930.911.0
0.680.410.430.380.70.640.520.2-0.51-0.360.40.490.29-0.210.580.660.730.480.540.740.750.640.470.50.2
-0.92-0.89-0.91-0.88-0.92-0.87-0.94-0.8-0.510.88-0.8-0.99-0.830.27-0.67-0.65-0.89-0.85-0.87-0.37-0.87-0.94-0.93-0.92-0.82
-0.82-0.99-0.97-0.95-0.79-0.82-0.93-0.97-0.360.88-0.97-0.93-0.960.22-0.28-0.68-0.76-0.93-0.88-0.22-0.8-0.86-0.98-0.96-0.98
0.810.980.930.920.780.810.910.940.4-0.8-0.970.860.94-0.180.170.780.750.960.850.340.810.840.950.930.93
0.920.940.950.920.910.890.960.860.49-0.99-0.930.860.89-0.250.590.680.880.90.880.350.870.930.970.960.88
0.770.960.970.980.740.810.920.990.29-0.83-0.960.940.890.040.290.670.70.930.80.210.690.770.950.940.98
-0.18-0.19-0.050.05-0.190.01-0.06-0.04-0.210.270.22-0.18-0.250.040.07-0.1-0.18-0.07-0.310.08-0.41-0.38-0.18-0.09-0.12
0.650.320.450.420.680.630.550.190.58-0.67-0.280.170.590.290.070.320.690.340.410.50.520.540.430.470.2
0.770.730.680.650.760.680.730.620.66-0.65-0.680.780.680.67-0.10.320.740.830.70.510.820.810.730.720.6
0.990.80.840.80.990.950.920.630.73-0.89-0.760.750.880.7-0.180.690.740.830.850.740.940.930.860.880.63
0.870.960.940.930.850.870.950.910.48-0.85-0.930.960.90.93-0.070.340.830.830.830.430.840.870.960.960.89
0.90.890.870.840.880.840.880.790.54-0.87-0.880.850.880.8-0.310.410.70.850.830.420.880.920.90.880.8
0.650.320.370.360.680.690.50.10.74-0.37-0.220.340.350.210.080.50.510.740.430.420.630.50.380.450.07
0.940.840.80.750.940.860.860.650.75-0.87-0.80.810.870.69-0.410.520.820.940.840.880.630.970.870.860.67
0.960.880.860.810.950.850.90.740.64-0.94-0.860.840.930.77-0.380.540.810.930.870.920.50.970.910.890.76
0.90.990.990.970.890.90.980.930.47-0.93-0.980.950.970.95-0.180.430.730.860.960.90.380.870.910.990.94
0.920.970.990.980.90.940.990.910.5-0.92-0.960.930.960.94-0.090.470.720.880.960.880.450.860.890.990.91
0.710.960.940.940.680.730.871.00.2-0.82-0.980.930.880.98-0.120.20.60.630.890.80.070.670.760.940.91
Click cells to compare fundamentals

BeiGene Account Relationship Matchups

BeiGene fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.6B5.6B8.6B6.4B5.8B3.2B
Short Long Term Debt Total277.3M562.0M694.6M891.1M930.2M976.7M
Other Current Liab152.7M445.7M705.6M538.8M739.8M776.8M
Total Current Liabilities286.0M1.1B1.6B1.0B1.8B1.9B
Total Stockholder Equity978.4M3.9B6.2B4.4B3.5B2.2B
Other Liab57.1M443.3M562.5M283.7M326.3M342.6M
Net Tangible Assets956.3M3.9B6.2B4.3B5.0B5.2B
Property Plant And Equipment Net313.1M446.3M686.7M845.9M1.4B1.5B
Net Debt(340.7M)(820.0M)(3.7B)(3.0B)(2.2B)(2.1B)
Retained Earnings(2.0B)(3.6B)(5.0B)(7.1B)(8.0B)(7.6B)
Accounts Payable122.5M232.0M168.0M294.8M315.1M330.9M
Cash618.0M1.4B4.4B3.9B3.2B3.3B
Non Current Assets Total439.6M640.1M1.0B845.9M1.6B1.7B
Non Currrent Assets Other2.5M24.6M30.7M(186.5M)35.7M37.5M
Other Assets108.7M186.8M8.6B819.9M2.01.9
Long Term Debt240.7M183.6M202.1M209.1M197.6M143.1M
Cash And Short Term Investments985.5M4.7B6.6B4.5B3.2B2.3B
Common Stock Total Equity77K79K118K133K153.0K160.6K
Common Stock Shares Outstanding60.1M83.5M92.8M103.1M104.4M72.1M
Short Term Investments364.7M3.3B2.2B665.3M2.6M2.5M
Liabilities And Stockholders Equity1.6B5.6B8.6B6.4B5.8B3.2B
Non Current Liabilities Total347.9M656.3M803.4M977.9M457.8M376.4M
Other Current Assets85.8M141.0M253.1M288.2M205.5M111.8M
Other Stockholder Equity2.9B7.4B11.2B11.5B11.6B12.2B
Total Liab633.9M1.7B2.4B2.0B2.3B2.4B
Property Plant And Equipment Gross324.9M399.5M811.0M1.1B1.6B1.7B
Total Current Assets1.2B5.0B7.6B4.7B4.2B2.6B
Accumulated Other Comprehensive Income(8.0M)6.9M18.0M(77.4M)(99.4M)(94.5M)
Short Term Debt10.8M362.8M471.4M377.1M732.3M768.9M
Common Stock79K118K133K135K155.3K83.2K
Property Plant Equipment324.9M357.7M587.6M955.9M1.1B1.2B
Deferred Long Term Liab11.1M10.5M10.8M14.2M16.3M10.1M
Long Term Debt Total189.7M240.7M183.6M202.1M232.4M156.4M
Capital Surpluse2.7B2.9B7.4B11.2B12.9B13.5B
Net Receivables72.8M79.7M500.2M173.2M395.9M415.7M
Retained Earnings Total Equity(1.0B)(2.0B)(3.6B)(5.0B)(4.5B)(4.2B)
Inventory28.6M89.3M242.6M282.3M416.1M436.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.19)
Revenue Per Share
225.239
Quarterly Revenue Growth
0.395
Return On Assets
(0.1)
Return On Equity
(0.23)
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.